News
The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...
17h
Stockhead on MSNIsland fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ virusesIsland will now focus on using the FDA’s animal rule to advance the Galidesivir program towards a new drug application (NDA), ...
The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...
16h
Stockhead on MSNHealth Check: POTUS puts drug tariffs back on agenda… another case of TACO?POTUS threatens a foreign drug tariff, but gives Big Pharma more time to shift production onshore ASX drug makers say they ...
15h
Stockhead on MSNLunch Wrap: ASX hits the brakes, rotating into defensive stocksThe ASX fell 0.31pc by lunchtime in the east, sliding as traders rotated into defensive utilities stocks. ... Read More The ...
Island Pharmaceuticals Ltd (ASX: ILA), an Australian antiviral drug development company focused on areas of unmet need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results